Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Yang HS, Edinboro L. Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS. Methods Mol Biol. 2019;1872:67-73.

Tierney JF, Vogle A, Poirier J, Min IM, Finnerty B, Zarnegar R, et al. Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study. Surgery. 2019;165(1):196-201.

Liu D, Fiel RH, Cheng LS, Ogami T, Wang L, Singh V, et al. Notes from the Field: First Reported Case of Shewanella haliotis in the Region of the Americas - New York, December 2018. MMWR Morb Mortal Wkly Rep. 2019;68(50):1168-1169.

Magro CM, Halteh P, Olson LC, Kister I, Shapiro L. Linear scleroderma "en coup de sabre" with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy. Orphanet J Rare Dis. 2019;14(1):110.

Hissong E, Fernandes H, Jessurun J. Colonic Mucosa With Polypoid Hyperplasia. Am J Clin Pathol. 2019;152(4):423-430.

Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, et al. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. Int J Gynecol Pathol. 2019;38 Suppl 1:S114-S122.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, et al. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204.

Cushing MM, Pagano MB, Jacobson J, Schwartz J, Grossman BJ, Kleinman S, et al. Pathogen reduced plasma products: a clinical practice scientific review from the AABB. Transfusion. 2019;59(9):2974-2988.

Chidambaram S, Pannullo SC, Roytman M, Pisapia DJ, Liechty B, Magge RS, et al. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery. Neurosurg Focus. 2019;46(6):E10.

Gambi G, Di Simone E, Basso V, Ricci L, Wang R, Verma A, et al. The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3. Cancer Res. 2019;79(12):3076-3087.